Impact Of Chronic Kidney Disease On The Pharmacodynamic And Pharmacokinetic Effects Of Ticagrelor In Patients With Diabetes Mellitus And Coronary Artery Disease.
Francesco FranchiFabiana RolliniLatonya BeenNaji MaalikiPatrick Abou JaoudeAndrea RivasXuan ZhouSida JiaMaryuri BricenoChang Hoon LeeAndres M PinedaSiva SuryadevaraDaniel SofferMartin M ZenniTheodore A BassDominick J AngiolilloPublished in: European heart journal. Cardiovascular pharmacotherapy (2021)
http://www.clinicaltrials.gov Unique Identifier: NCT02539160.
Keyphrases
- chronic kidney disease
- coronary artery disease
- percutaneous coronary intervention
- end stage renal disease
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- coronary artery bypass grafting
- antiplatelet therapy
- cardiovascular events
- glycemic control
- peritoneal dialysis
- aortic stenosis
- adipose tissue
- cardiovascular disease
- skeletal muscle
- transcatheter aortic valve replacement